The A148T Variant of the CDKN2A Gene Is Not Associated with Melanoma Risk in the French and Italian Populations
- 1 July 2006
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 126 (7) , 1657-1660
- https://doi.org/10.1038/sj.jid.5700293
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A mutation hotspot at the p14ARF splice siteOncogene, 2005
- An Assessment of the CDKN2A Variant Ala148Thr as a Nevus/Melanoma Susceptibility AlleleJournal of Investigative Dermatology, 2002
- Germline mutation of ARF in a melanoma kindredHuman Molecular Genetics, 2002
- CDKN2A Variants in a Population-Based Sample of Queensland Families With MelanomaJNCI Journal of the National Cancer Institute, 1999
- Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group [published erratum appears in Hum Mol Genet 1998 May;7(5):941]Human Molecular Genetics, 1998
- Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population.Proceedings of the National Academy of Sciences, 1996
- Mutations of the CDKN2/p16INK4 gene in Australian melanoma kindredsHuman Molecular Genetics, 1995
- Mutations associated with familial melanoma impair p16INK4 functionNature Genetics, 1995
- Germline p16 mutations in familial melanomaNature Genetics, 1994
- Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locusNature Genetics, 1994